Meet Intertek at AsiaTIDES 2020
Discuss your oligonucleotide and peptide development challenges with our team at AsiaTIDES 2020 (24-26 February), Kyoto, Japan.
Intertek can support your oligonuclotide and peptide development from early stage characterisation to late-stage development and commercialisation. Arrange a meeting with one of our experts to discuss how to overcome your current analytical challenges, visit Stand #21.
LEARN MORE ABOUT OUR SERVICES OLIGONUCLEOTIDE AND PEPTIDE ANALYSIS
Case Study: Identification Testing by Accurate Mass and MS/MS Sequencing
Case Study: Oligonucleotide Identification, Assay and Impurities
Case Study: Determination of Melting Temperature for Oligonucleotide Duplexes using NMR
Article Download: Analytical challenges in the oligonucleotide characterisation
White Paper: Analytical Strategies for Quality Control of Oligonucleotide Therapeutics
With a growing global development pipeline of oligonucleotide therapeutics to treat a variety of disease targets, overcoming the challenges of innovation, regulatory authorization, production and the inherent complexity of oligos is critical to success. Contact our experts in oligonucleotide analysis and bioanalysis, to discuss our regulatory-driven, phase-appropriate characterization and biophysical analysis in support of CMC programs with GMP and CMC laboratory services, pharmaceutical analysis, quality control analysis, elemental impurities, extractables and leachables, stability programs, inhalation drug development,and method development and method validation. We will be available to review your challenges and discuss how our unrivalled expertise can help you accelerate the development timelines.
Need help or have a question?